Adverse Events Resulting in After-Hours Calls After Mohs Micrographic Surgery

    loading  Checking for direct PDF access through Ovid

Excerpt

In 2012, it was estimated that over 5.4 million nonmelanoma skin cancers were diagnosed annually in the United States, and the incidence is rising.1 Previous studies have shown that Mohs micrographic surgery (MMS) and outpatient dermatologic surgeries are safe procedures with low complication rates.2–4 Two recent prospective studies have shown that infection (1.3%–1.32%) and bleeding (0.41%–0.89%) are the 2 most common adverse events.2,3 However, previous studies have been unable to link complications with specific procedures or anatomical sites.2,3 Our survey assesses specific factors related to adverse events in the immediate postoperative period, which we defined as within 7 days, after dermatologic surgery.
    loading  Loading Related Articles